Australian API Manufacturer Hit for Quality Failures, Non-Conformance

The FDA issued a Form 483 to active pharmaceutical ingredient manufacturer IDT Australia citing quality shortcomings and other deviations observed during a December inspection of its Boronia, Victoria, facility.
Source: Drug Industry Daily